Is a complete TELA research report available?

No complete published report is available for TELA Bio, Inc. (TELA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TELA Bio, Inc. (TELA)

NASDAQ: TELA · USD

$0.97

+0.01 (+1.0%)· Recorded snapshot

Market cap	43.8M
Revenue (ttm)	79.9M
Net income (ttm)	-41.2M
EPS (ttm)	-$0.78
Shares out	45.1M
Volume	58,097
Beta	1.36

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 79.9M
Net income (ttm): -41.2M
EPS (ttm): -$0.78
Market cap: 43.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantenere

Metric	Value
Amount currency	USD
CIK code	0001561921
Company name	TELA Bio, Inc.
Country	United States
Country code	US
CUSIP number	872381108
Earnings date	2026-11-10
Earnings time	amc
Employees	218
Employees change	9
Employees growth	4.31%
Enterprise value	$71.3M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2012
Industry	Medical Devices
IPO date	2019-11-08
Is primary listing	Yes
Is SPAC	No
ISIN number	US8723811084
Last 10-K release date	2026-03-25
Last earnings date	2026-08-10
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$43.8M
Market cap category	Nano-Cap
Next earnings date	2026-11-10
Options	Yes
Price	$0.97
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	TELA
U.S. state	Pennsylvania
Website	https://www.telabio.com

Metric

Value

Amount currency

USD

CIK code

0001561921

Company name

TELA Bio, Inc.

Country

United States

Country code

CUSIP number

872381108

Earnings date

2026-11-10

Earnings time

amc

Employees

218

Employees change

Employees growth

4.31%

Enterprise value

$71.3M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2012

Industry

Medical Devices

IPO date

2019-11-08

Is primary listing

Yes

Is SPAC

ISIN number

US8723811084

Last 10-K release date

2026-03-25

Last earnings date

2026-08-10

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$43.8M

Market cap category

Nano-Cap

Next earnings date

2026-11-10

Options

Yes

Price

$0.97

Price currency

USD

Sector

Healthcare

SIC code

3841

Stock price date

2026-10-28

Symbol

TELA

U.S. state

Pennsylvania

Website

https://www.telabio.com

Metric	Value
Earnings yield	-80.18%
EV/Sales	0.89x
FCF / EV yield	-44.64%
FCF yield	-72.96%
Forward EV/Sales	0.86x
Forward P/S	0.53x
Industry forward P/E	19.81x
Industry P/E	39.28x
P/S ratio	0.54x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-80.18%

EV/Sales

0.89x

FCF / EV yield

-44.64%

FCF yield

-72.96%

Forward EV/Sales

0.86x

Forward P/S

0.53x

Industry forward P/E

19.81x

Industry P/E

39.28x

P/S ratio

0.54x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	-42.56%
EBITDA margin	-41.31%
Gross margin	68.29%
Operating margin	-42.56%
Pretax margin	-51.2%
Profit margin	-51.53%
Profit per employee	$-188,894
Revenue per employee	$366,550
ROA	-33.4%
ROA (5Y)	-31.33%
ROCE	-81.91%
ROE (5Y)	-203.65%
ROIC	-45.05%
SBC / revenue	4%
Tax / revenue	0.33%

Metric

Value

EBIT margin

-42.56%

EBITDA margin

-41.31%

Gross margin

68.29%

Operating margin

-42.56%

Pretax margin

-51.2%

Profit margin

-51.53%

Profit per employee

$-188,894

Revenue per employee

$366,550

ROA

-33.4%

ROA (5Y)

-31.33%

ROCE

-81.91%

ROE (5Y)

-203.65%

ROIC

-45.05%

SBC / revenue

Tax / revenue

0.33%

Metric	Value
EPS growth quarters	2
EPS growth years	3
Gross profit growth	6.83%
Gross profit growth (Q)	-1.14%
Gross profit growth 3Y	17.11%
Gross profit growth 5Y	28.12%
Net income growth years	0
Revenue growth	6.09%
Revenue growth (Q)	-4.49%
Revenue growth (QoQ)	1.22%
Revenue growth 3Y	17.56%
Revenue growth 5Y	26.76%
Revenue growth years	8

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

6.83%

Gross profit growth (Q)

-1.14%

Gross profit growth 3Y

17.11%

Gross profit growth 5Y

28.12%

Net income growth years

Revenue growth

6.09%

Revenue growth (Q)

-4.49%

Revenue growth (QoQ)

1.22%

Revenue growth 3Y

17.56%

Revenue growth 5Y

26.76%

Revenue growth years

Metric	Value
Capital expenditures	$-480,000
Depreciation and amortization	$1M
EBIT	$-34M
EBITDA	$-33M
EPS	$-0.78
FCF per share	$-0.70
Financing cash flow	$25.6M
Free cash flow	$-31.6M
Free cash flow minus SBC	$-34.8M
Gross profit	$54.6M
Income taxes	$265,000
Investing cash flow	$933,000
Net borrowing	$17.6M
Net cash flow	$-4.6M
Net income	$-41.2M
Operating cash flow minus SBC	$-34.3M
Operating income	$-34M
Revenue	$79.9M
Stock-based compensation	$3.2M

Metric

Value

Capital expenditures

$-480,000

Depreciation and amortization

$1M

EBIT

$-34M

EBITDA

$-33M

EPS

$-0.78

FCF per share

$-0.70

Financing cash flow

$25.6M

Free cash flow

$-31.6M

Free cash flow minus SBC

$-34.8M

Gross profit

$54.6M

Income taxes

$265,000

Investing cash flow

$933,000

Net borrowing

$17.6M

Net cash flow

$-4.6M

Net income

$-41.2M

Operating cash flow minus SBC

$-34.3M

Operating income

$-34M

Revenue

$79.9M

Stock-based compensation

$3.2M

Metric	Value
Altman Z-Score	-9.29
Book value per share	$-0.35
Interest coverage	-4.88
Long-term assets	$5.2M
Long-term liabilities	$57.4M
Net cash (debt)	$-27.5M
Net cash / market cap	-63.44%
Piotroski F-Score	3
Property, plant and equipment	$3.4M
Shareholders' equity	$-15.9M
Tangible book value	$-17M
Tangible book value per share	$-0.38
Total assets	$59.7M
Total cash	$30.4M
Total debt	$57.9M
Total liabilities	$75.6M
WACC	10.46%

Metric

Value

Altman Z-Score

-9.29

Book value per share

$-0.35

Interest coverage

-4.88

Long-term assets

$5.2M

Long-term liabilities

$57.4M

Net cash (debt)

$-27.5M

Net cash / market cap

-63.44%

Piotroski F-Score

Property, plant and equipment

$3.4M

Shareholders' equity

$-15.9M

Tangible book value

$-17M

Tangible book value per share

$-0.38

Total assets

$59.7M

Total cash

$30.4M

Total debt

$57.9M

Total liabilities

$75.6M

WACC

10.46%

Metric	Value
Asset turnover	1.26
Current assets	$54.5M
Current liabilities	$18.2M
Current ratio	2.99
Inventory turnover	2.26
Net working capital	$6.4M
Quick ratio	2.2
Working capital	$36.3M
Working capital turnover	2.05

Metric

Value

Asset turnover

1.26

Current assets

$54.5M

Current liabilities

$18.2M

Current ratio

2.99

Inventory turnover

2.26

Net working capital

$6.4M

Quick ratio

2.2

Working capital

$36.3M

Working capital turnover

2.05

Metric	Value
Buyback yield / dilution	-36.23%
Dividend yield	0%
Shareholder yield	-36.23%

Metric

Value

Buyback yield / dilution

-36.23%

Dividend yield

Shareholder yield

-36.23%

Metric	Value
150-day SMA	$0.86
1D price change	1.02%
1M price change	-23.81%
1M total return	-23.81%
1W price change	-11.93%
1W total return	-11.93%
1Y price change	-35.14%
1Y return CAGR	-35.15%
1Y total return	-35.14%
20-day SMA	$1.06
200-day SMA	$0.86
3M price change	47.69%
3M total return	47.69%
3Y price change	-83.51%
3Y return CAGR	-45.15%
3Y total return	-83.51%
50-day SMA	$1.00
50-day SMA vs 200-day SMA	50over200
52-week high	$1.51
52-week high date	2025-10-28
52-week low	$0.50
52-week low date	2026-04-02
5Y price change	-92.26%
5Y return CAGR	-40.06%
5Y total return	-92.26%
6M price change	20.05%
6M total return	20.05%
All-time high	$23.55
All-time high date	2020-06-19
All-time low	$0.50
All-time low date	2026-04-02
Average true range (ATR)	$0.11
Average volume	137.1K
Beta (1Y)	1.76
Beta (2Y)	0.99
Beta (5Y)	1.36
Change from 52-week high	-35.56%
Change from 52-week low	93.53%
Change from all-time high	-95.92%
Change from all-time low	91.58%
Change from open	-1.28%
Day's gap	2.33%
Dollar volume	$56,342
High price	$0.98
Low price	$0.96
Monthly RSI	36.08
Open price	$0.98
Position in 52-week range	43.75%
Previous close	$0.96
Price vs 150-day SMA	11.56%
Price vs 20-day SMA	-9%
Price vs 200-day SMA	11.82%
Price vs 50-day SMA	-3.87%
Relative volume	0.42
Return from IPO open	-93.02%
Return from IPO price	-92.62%
RSI	42.65
Sharpe ratio	-0.04
Sharpe ratio (3Y)	-0.38
Sharpe ratio (5Y)	-0.43
Sortino ratio	0
Sortino ratio (3Y)	-0.47
Sortino ratio (5Y)	-0.52
Volume	58.1K
Weekly RSI	50.67
YTD price change	-18.64%
YTD total return	-18.64%

Metric

Value

150-day SMA

$0.86

1D price change

1.02%

1M price change

-23.81%

1M total return

-23.81%

1W price change

-11.93%

1W total return

-11.93%

1Y price change

-35.14%

1Y return CAGR

-35.15%

1Y total return

-35.14%

20-day SMA

$1.06

200-day SMA

$0.86

3M price change

47.69%

3M total return

47.69%

3Y price change

-83.51%

3Y return CAGR

-45.15%

3Y total return

-83.51%

50-day SMA

$1.00

50-day SMA vs 200-day SMA

50over200

52-week high

$1.51

52-week high date

2025-10-28

52-week low

$0.50

52-week low date

2026-04-02

5Y price change

-92.26%

5Y return CAGR

-40.06%

5Y total return

-92.26%

6M price change

20.05%

6M total return

20.05%

All-time high

$23.55

All-time high date

2020-06-19

All-time low

$0.50

All-time low date

2026-04-02

Average true range (ATR)

$0.11

Average volume

137.1K

Beta (1Y)

1.76

Beta (2Y)

0.99

Beta (5Y)

1.36

Change from 52-week high

-35.56%

Change from 52-week low

93.53%

Change from all-time high

-95.92%

Change from all-time low

91.58%

Change from open

-1.28%

Day's gap

2.33%

Dollar volume

$56,342

High price

$0.98

Low price

$0.96

Monthly RSI

36.08

Open price

$0.98

Position in 52-week range

43.75%

Previous close

$0.96

Price vs 150-day SMA

11.56%

Price vs 20-day SMA

-9%

Price vs 200-day SMA

11.82%

Price vs 50-day SMA

-3.87%

Relative volume

0.42

Return from IPO open

-93.02%

Return from IPO price

-92.62%

RSI

42.65

Sharpe ratio

-0.04

Sharpe ratio (3Y)

-0.38

Sharpe ratio (5Y)

-0.43

Sortino ratio

Sortino ratio (3Y)

-0.47

Sortino ratio (5Y)

-0.52

Volume

58.1K

Weekly RSI

50.67

YTD price change

-18.64%

YTD total return

-18.64%

Metric	Value
Float	21.3M
Float percentage	47.2%
Shares change (QoQ)	0.28%
Shares change (YoY)	36.23%
Shares held by insiders	8.6%
Shares held by institutions	21.16%
Shares outstanding	45.1M
Short % of float	2.2%
Short % of shares	1.04%
Short ratio	1.7 days

Metric

Value

Float

21.3M

Float percentage

47.2%

Shares change (QoQ)

0.28%

Shares change (YoY)

36.23%

Shares held by insiders

8.6%

Shares held by institutions

21.16%

Shares outstanding

45.1M

Short % of float

2.2%

Short % of shares

1.04%

Short ratio

1.7 days

TELA Bio, Inc. (TELA)

Price

Financial snapshot

Fair-value bridge

Latest news · TELA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TELA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TELA

Frequently asked questions